CVRX

SEC source: 0001644355-26-000007 · form4-08142026_120854.xml · nonDerivative · entry 1

Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 56,514

F1 · price: Reflects the weighted average price of 26,223 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on August 13, 2026 with purchase prices ranging from $2.87 to $2.96 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001644355-26-000005 · form4-08132026_080826.xml · nonDerivative · entry 1

Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 30,291

F1 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

F2 · price: Reflects the weighted average price of 1,309 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on August 12, 2026 with sale prices ranging from $2.55 to $2.564 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001172346-26-000004 · form4-06032026_100618.xml · derivative · entry 2

DALE MICHAEL D · CIK 0001172346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,252

Underlying: Common Stock · 36,252 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Vests as to one-third of the shares on each annual anniversary of the date of grant.

SEC source: 0001172346-26-000004 · form4-06032026_100618.xml · nonDerivative · entry 1

DALE MICHAEL D · CIK 0001172346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,005

F1 · shares: Vests as to one-third of the shares on each annual anniversary of the date of grant.

SEC source: 0001871700-26-000002 · form4-06032026_100622.xml · derivative · entry 2

SHADAN MARTHA · CIK 0001871700 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,182

Underlying: Common Stock · 11,182 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001871700-26-000002 · form4-06032026_100622.xml · nonDerivative · entry 1

SHADAN MARTHA · CIK 0001871700 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,720

F1 · shares: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001246530-26-000002 · form4-06032026_100653.xml · derivative · entry 2

SLATTERY JOSEPH P · CIK 0001246530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,182

Underlying: Common Stock · 11,182 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001246530-26-000002 · form4-06032026_100653.xml · nonDerivative · entry 1

SLATTERY JOSEPH P · CIK 0001246530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,365

F1 · shares: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001584404-26-000006 · form4-06032026_100618.xml · derivative · entry 3

Jain Mudit K. · CIK 0001584404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,182

Underlying: Common Stock · 11,182 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001584404-26-000006 · form4-06032026_100618.xml · nonDerivative · entry 1

Jain Mudit K. · CIK 0001584404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,370

F1 · shares: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001523522-26-000007 · form4-06032026_100643.xml · derivative · entry 3

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,182

Underlying: Common Stock · 11,182 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001523522-26-000007 · form4-06032026_100643.xml · nonDerivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,720

F1 · shares: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001566080-26-000002 · form4-06032026_100659.xml · derivative · entry 2

Ballinger Kevin J. · CIK 0001566080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,182

Underlying: Common Stock · 11,182 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001566080-26-000002 · form4-06032026_100659.xml · nonDerivative · entry 1

Ballinger Kevin J. · CIK 0001566080 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,720

F1 · shares: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001644989-26-000002 · form4-06032026_100625.xml · derivative · entry 2

Hill, Mitch C. · CIK 0001644989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 11,182

Underlying: Common Stock · 11,182 shares

Expires 2036-06-01

F1 · derivative.exercise_date: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0001644989-26-000002 · form4-06032026_100625.xml · nonDerivative · entry 1

Hill, Mitch C. · CIK 0001644989 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,720

F1 · shares: Vests on the earlier of June 1, 2027 or the Issuer's 2027 annual meeting of stockholders.

SEC source: 0002028875-26-000002 · form4-03032026_110339.xml · nonDerivative · entry 2

John Robert Allen · CIK 0002028875 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 86,036

F2 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

F3 · price: Reflects the weighted average price of 3,964 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.994 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001869707-26-000002 · form4-03032026_110313.xml · nonDerivative · entry 2

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 96,703

F2 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

F3 · price: Reflects the weighted average price of 1,744 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.9831 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001869761-26-000002 · form4-03032026_110358.xml · nonDerivative · entry 2

VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 60,551

F2 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

F3 · price: Reflects the weighted average price of 1,284 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $7.98 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001467748-26-000002 · form4-03032026_110335.xml · nonDerivative · entry 2

Hykes Kevin · CIK 0001467748 · Director · PRES & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 284,237

F2 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

F3 · price: Reflects the weighted average price of 7,763 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $8.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0001329922-26-000006 · form4-03042026_090343.xml · derivative · entry 2

Morrison Gregory · CIK 0001329922 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 154,500

Underlying: Common Stock · 154,500 shares

Expires 2036-03-01

F2 · derivative.exercise_date: Vests as to 25% of the shares on March 2, 2027 and as to 1/48th of the shares each month thereafter.

SEC source: 0001329922-26-000006 · form4-03042026_090343.xml · nonDerivative · entry 1

Morrison Gregory · CIK 0001329922 · CHIEF HUMAN RESOURCES OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 34,000

F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

SEC source: 0002056191-26-000004 · form4-03162026_080309.xml · nonDerivative · entry 2

Adamson Philip B. · CIK 0002056191 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,578

F3 · kind: The sale was mandated by the issuer's award agreement to satisfy tax withholding obligations by a sell-to-cover transaction.

F4 · price: Reflects the weighted average price of 1,262 shares of common stock of CVRx, Inc. sold by the reporting person in multiple transactions on March 2, 2026 with sale prices ranging from $7.90 to $8.00 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.

SEC source: 0002028875-26-000002 · form4-03032026_110339.xml · derivative · entry 3

John Robert Allen · CIK 0002028875 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 52,000

Underlying: Common Stock · 52,000 shares

Expires 2036-02-26

F4 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

SEC source: 0002028875-26-000002 · form4-03032026_110339.xml · nonDerivative · entry 1

John Robert Allen · CIK 0002028875 · Chief Revenue Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 90,000

F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

SEC source: 0001869707-26-000002 · form4-03032026_110313.xml · derivative · entry 3

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 91,000

Underlying: Common Stock · 91,000 shares

Expires 2036-02-26

F4 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

SEC source: 0001869707-26-000002 · form4-03032026_110313.xml · nonDerivative · entry 1

OASHEIM JARED · CIK 0001869707 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 98,447

F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

SEC source: 0001869761-26-000002 · form4-03032026_110358.xml · derivative · entry 3

VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 67,000

Underlying: Common Stock · 67,000 shares

Expires 2036-02-26

F4 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

SEC source: 0001869761-26-000002 · form4-03032026_110358.xml · nonDerivative · entry 1

VERRASTRO PAUL · CIK 0001869761 · CHIEF MKTG & STRAT OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 61,835

F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

SEC source: 0001467748-26-000002 · form4-03032026_110335.xml · derivative · entry 3

Hykes Kevin · CIK 0001467748 · Director · PRES & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 238,000

Underlying: Common Stock · 238,000 shares

Expires 2036-02-26

F4 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

SEC source: 0001467748-26-000002 · form4-03032026_110335.xml · nonDerivative · entry 1

Hykes Kevin · CIK 0001467748 · Director · PRES & CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 292,000

F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

SEC source: 0001644355-26-000002 · form4-03032026_110346.xml · derivative · entry 2

Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,000

Underlying: Common Stock · 23,000 shares

Expires 2036-02-26

F2 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

SEC source: 0001644355-26-000002 · form4-03032026_110346.xml · nonDerivative · entry 1

Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 31,600

F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

SEC source: 0002056191-26-000004 · form4-03162026_080309.xml · derivative · entry 3

Adamson Philip B. · CIK 0002056191 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,000

Underlying: Common Stock · 62,000 shares

Expires 2036-02-26

F5 · derivative.exercise_date: Vests as to 25% of the shares on February 27, 2027 and as to 1/48th of the shares each month thereafter.

SEC source: 0002056191-26-000004 · form4-03162026_080309.xml · nonDerivative · entry 1

Adamson Philip B. · CIK 0002056191 · Chief Medical Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 62,840

F1 · shares: Restricted stock units that vest as to 25% of the shares on each annual anniversary of the grant date.

F2 · balance_after: Includes 1,840 shares acquired under Issuer's Employee Stock Purchase Plan.

SEC source: 0001584404-26-000004 · form4-02232026_060201.xml · nonDerivative · entry 1

Jain Mudit K. · CIK 0001584404 · Director

10b5-1 filing: No plan indicated

Ownership: Indirect · See footnote

Disclosed balance after: 980,183

F1 · price: Reflects the weighted average price of 46,800 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on February 20, 2026 with purchase prices ranging from $5.8500 to $6.3868 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

F2 · ownership.nature: These shares are held directly by Treo Ventures I, L.P ("Treo"). The Reporting Person is the General Partner of Treo and shares voting and dispositive power over the shares held by Treo. The Reporting Person disclaims beneficial ownership of all applicable shares except to the extent of his actual pecuniary interest in such shares.

SEC source: 0001584404-26-000002 · form4-02182026_100222.xml · nonDerivative · entry 1

Jain Mudit K. · CIK 0001584404 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,650

F1 · price: Reflects the weighted average price of 600 shares of common stock of CVRx, Inc. purchased by the reporting person in multiple transactions on February 18, 2026 with purchase prices ranging from $4.63 to $4.65 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.

SEC source: 0001193125-25-303876 · ownership.xml · nonDerivative · entry 1

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,040,861

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001193125-26-007679 · ownership.xml · nonDerivative · entry 2

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,024,861

F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.23. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001193125-26-007679 · ownership.xml · nonDerivative · entry 1

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,031,198

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.22. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001193125-25-296047 · ownership.xml · nonDerivative · entry 2

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,047,198

F2 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.10. The Reporting Person undertakes to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001193125-25-296047 · ownership.xml · nonDerivative · entry 1

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,049,398

F1 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001193125-25-282669 · ownership.xml · nonDerivative · entry 1

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,049,898

F1 · price: The price reported in Column 4 is a weighted average price. 29 shares were sold at $10.04 and 971 shares were sold at $10.00.

F2 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001193125-25-274067 · ownership.xml · nonDerivative · entry 2

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,050,898

F2 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001193125-25-274067 · ownership.xml · nonDerivative · entry 1

JOHNSON & JOHNSON · CIK 0000200406 · 10% owner

Johnson & Johnson Innovation - JJDC, Inc. · CIK 0000924020 · 10% owner

Joint disclosure: these amounts are not allocated separately to each reporting owner.

10b5-1 filing: No plan indicated

Ownership: Indirect · By Johnson & Johnson Innovation - JJDC, Inc.

Disclosed balance after: 4,051,098

F1 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.00 to $10.49. The Reporting Persons undertake to provide to the Issuer, any shareholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F2 · ownership.nature: The securities reported as being indirectly beneficially owned by Johnson & Johnson, the designated Reporting Person, are directly beneficially owned by Johnson & Johnson Innovation - JJDC, Inc. ("JJDC"). JJDC is a wholly-owned subsidiary of Johnson & Johnson.

SEC source: 0001415889-25-021649 · form4-08132025_080828.xml · derivative · entry 2

Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,900

Underlying: Common Stock · 74,900 shares

Expires 2035-08-10

F2 · derivative.exercise_date: Stock options that vest 25% on the first annual anniversary of the date of grant and then 1/48th per month thereafter.

SEC source: 0001415889-25-021649 · form4-08132025_080828.xml · nonDerivative · entry 1

Binkowski Brent · CIK 0001644355 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,600

F1 · shares: Restricted stock units that vest 25% on each anniversary of the grant date

SEC source: 0001415889-25-015806 · form4-06052025_090604.xml · derivative · entry 1

SHADAN MARTHA · CIK 0001871700 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,554

Underlying: Common Stock · 19,554 shares

Expires 2035-06-03

F1 · derivative.exercise_date: Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001415889-25-015809 · form4-06052025_090603.xml · derivative · entry 1

SLATTERY JOSEPH P · CIK 0001246530 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,554

Underlying: Common Stock · 19,554 shares

Expires 2035-06-03

F1 · derivative.exercise_date: Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders.

SEC source: 0001415889-25-015816 · form4-06052025_090637.xml · derivative · entry 1

Nielsen Kirk G. · CIK 0001523522 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,554

Underlying: Common Stock · 19,554 shares

Expires 2035-06-03

F1 · derivative.exercise_date: Vests on the earlier of June 3, 2026 or the Issuer's 2026 annual meeting of stockholders.